Report - BMN673,aNovelandHighlyPotentPARP1/2Inhibitorforthe ... · profoundly sensitive to oral BMN 673 treatment at well-tolerated doses in mice. Synergistic or additive antitumor effects

Please pass captcha verification before submit form